Filing Details
- Accession Number:
- 0001127602-14-030979
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-04 14:17:54
- Reporting Period:
- 2014-11-03
- Filing Date:
- 2014-11-04
- Accepted Time:
- 2014-11-04 14:17:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141720 | F Thomas Ackerman | 251 Ballardvale Street Wilmington MA 01887 | Corp. Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-03 | 26,100 | $58.58 | 130,311 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-11-03 | 10,000 | $37.92 | 140,311 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-03 | 36,100 | $65.00 | 104,211 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2014-11-03 | 26,100 | $0.00 | 26,100 | $58.58 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2014-11-03 | 10,000 | $0.00 | 10,000 | $37.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-02-28 | 2015-02-28 | No | 4 | M | Direct |
| 35,000 | 2011-02-26 | 2017-02-26 | No | 4 | M | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
